Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc. (ESLA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ESLA · as of Jun 8, 2026
Key Statistics
Explore Estrella Immunopharma, Inc. Data
esla stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
esla competitorsESLA
ANEB
ATOS
EXOZ
GLSI
IMMXStock Performance
Full HistoryAbout Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc. is an early-stage biopharmaceutical enterprise focused on creating T-cell therapies for various blood cancers and solid tumors, with its primary activities centered in the …
what is estrella immunopharma, inc. · esla stock overview · estrella immunopharma, inc. company profile · who is estrella immunopharma, inc. ceo · esla NASDAQ · estrella immunopharma, inc. headquarters · estrella immunopharma, inc. business segments
About Stock Overview & Key Data
Estrella Immunopharma, Inc. (ESLA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 14, 2021. As of the latest trading session, ESLA stock price is $1.13, with a market capitalization of $48.6M. The stock has returned +14.30% over the past 12 months and -27.56% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Estrella Immunopharma, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Estrella Immunopharma, Inc. reported revenue of — and net income of -$13.1M. For detailed data — including Estrella Immunopharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Estrella Immunopharma, Inc. (ESLA) stock price is $1.13. The stock is traded on NASDAQ under the ticker symbol ESLA. The 52-week range is $0.78 – $3.15.